Free tool
Cell therapy stocks
We cover 13 companies grouped under the Cell therapy theme. The median market value in the group is $54.52M. Across the group, the median move over the past trading day is +0.35%. Price change over the past year runs from −59.1% to +61.9% across the middle 80 percent of the group, with a median of −23.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
13 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SYNC.L | Syncona Limited | 112.00 GBP | +4.67% | +17.28% | +17.03% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $8.19 | −2.04% | +216.33% | +265.60% |
| 0HX7.L | Adicet Bio, Inc. | $8.87 | −1.22% | +3.14% | −28.19% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $9.58 | −1.90% | −46.57% | −23.28% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| PTG.WA | Poltreg S.A. | 25.00 PLN | +9.17% | −1.96% | −14.68% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% |
| 0NLV.L | FamiCord AG | 2.78 EUR | −1.55% | −53.28% | −62.93% |
| F98.F | CytoMed Therapeutics Limited | 0.84 EUR | +12.08% | −73.06% | −50.30% |
| 0QFK.L | Celyad Oncology SA | 0.28 EUR | +8.20% | +58.29% | −9.18% |
| BSFA.L | BSF Enterprise Plc | 1.15 GBP | +43.75% | −39.47% | −48.89% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.